CochLear Shares Outstanding 2023-2025 | CHEOY
CochLear shares outstanding history from 2023 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- CochLear shares outstanding for the quarter ending June 30, 2025 were 0M, a 0% increase year-over-year.
- CochLear 2025 shares outstanding were 0.131B, a 0.17% decline from 2024.
- CochLear 2024 shares outstanding were 0.131B, a 0.27% decline from 2023.
- CochLear 2023 shares outstanding were 0.132B, a 0.19% increase from 2022.
|
CochLear Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 131 |
| 2024 | 131 |
| 2023 | 132 |
| 2022 | 132 |
| 2021 | 131 |
| 2020 | 119 |
| 2019 | 115 |
| 2018 | 115 |
| 2017 | 115 |
| 2016 | 114 |
|
CochLear Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-06-30 | |
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.879B | $1.525B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $155.220B | 28.17 |
| HCA Healthcare (HCA) | United States | $114.565B | 17.76 |
| CVS Health (CVS) | United States | $96.096B | 11.22 |
| Elevance Health (ELV) | United States | $71.870B | 10.79 |
| Cencora (COR) | United States | $69.838B | 22.03 |
| Natera (NTRA) | United States | $29.276B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.585B | 17.98 |
| DiDi Global (DIDIY) | China | $22.403B | 20.70 |
| Viatris (VTRS) | United States | $18.371B | 6.85 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.777B | 0.00 |
| Solventum (SOLV) | United States | $13.956B | 13.55 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.564B | 29.15 |
| Revvity (RVTY) | United States | $11.876B | 20.66 |
| ICON (ICLR) | Ireland | $11.673B | 11.58 |
| Charles River Laboratories (CRL) | United States | $8.920B | 17.18 |
| Sonic Healthcare (SKHHY) | Australia | $7.755B | 0.00 |
| Avantor (AVTR) | United States | $7.609B | 11.62 |
| BrightSpring Health Services (BTSG) | United States | $7.095B | 42.30 |
| HealthEquity (HQY) | United States | $6.694B | 25.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.255B | 0.00 |
| PACS (PACS) | United States | $6.182B | 37.59 |
| Bausch + Lomb (BLCO) | Canada | $6.076B | 39.88 |
| Sotera Health (SHC) | United States | $4.960B | 23.92 |
| Alignment Healthcare (ALHC) | United States | $4.128B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.058B | 19.09 |
| GeneDx Holdings (WGS) | United States | $2.740B | 48.11 |
| Establishment Labs Holdings (ESTA) | United States | $2.109B | 0.00 |
| Organon (OGN) | United States | $2.030B | 2.14 |
| Progyny (PGNY) | United States | $1.855B | 36.47 |
| Pediatrix Medical (MD) | United States | $1.811B | 10.81 |
| Surgery Partners (SGRY) | United States | $1.802B | 23.22 |
| Ardent Health (ARDT) | United States | $1.286B | 4.20 |
| InnovAge Holding (INNV) | United States | $1.136B | 167.40 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| Teladoc Health (TDOC) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.791B | 12.94 |
| Nutex Health (NUTX) | United States | $0.717B | 5.48 |
| Omada Health (OMDA) | United States | $0.656B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.646B | 0.00 |
| Embecta (EMBC) | United States | $0.609B | 3.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.604B | 0.00 |
| Enhabit (EHAB) | United States | $0.566B | 25.43 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.485B | 8.92 |
| CryoPort (CYRX) | United States | $0.436B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.393B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| So-Young (SY) | China | $0.374B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| Shoulder Innovations (SI) | United States | $0.272B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Agilon Health (AGL) | United States | $0.187B | 0.00 |
| Beauty Health (SKIN) | United States | $0.148B | 0.00 |
| LifeMD (LFMD) | United States | $0.147B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.113B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.074B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.07 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |